Trial Profile
Multicenter Extension Study To 104 Weeks To Asses The Efficacy, Safety And Immunogenicity Of Enerceptan® In Combination With Methotrexate For The Treatment Of Patients With Rheumatoid Arthritis
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Registrational
- Sponsors Amega Biotech; GEMA
- 22 Jan 2018 New trial record